• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-146a 抑制 CXCR4 的表达并改变结直肠癌细胞的存活、增殖和迁移率。

MiR-146a suppresses the expression of CXCR4 and alters survival, proliferation and migration rate in colorectal cancer cells.

机构信息

Department of Stem Cells and Regenerative Medicine, Institute for Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Box: 14965-161, Tehran, Iran.

Department of Stem Cells and Regenerative Medicine, Institute for Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Box: 14965-161, Tehran, Iran.

出版信息

Tissue Cell. 2021 Dec;73:101654. doi: 10.1016/j.tice.2021.101654. Epub 2021 Sep 20.

DOI:10.1016/j.tice.2021.101654
PMID:34601384
Abstract

CXCR4 plays an important role in colorectal cancer (CRC) development and metastasis. Some previous studies have indicated CXCR4 as a therapeutic target in cancer. CXCR4 is known as a direct target of miR-146a. The present study aimed to investigate how exogenous induction of miR-146a affects CXCR4 gene and protein expression and also proliferation, apoptosis and migration of CRC cells. Transfection of Caco-2 and SW480 cells by a synthetic miR-146a mimic led to downregulation of CXCR4 expression at both gene and protein levels. It also downregulated expression of several miR-146a targets, including GSK3B, IRAK1, TRAF6, AKT2, SMAD4, EGFR and NFKB1, mostly in SW480 cells. Overexpression of miR-146a resulted in a partial cell cycle arrest in the both cell lines, while the apoptotic rate was also decreased. In regards to epithelial-mesenchymal transition factors, VIM was downregulated in the both cell lines, but SNAI1 was upregulated in Caco-2 cells. The wound closure assay showed a reduction in cell migration in SW480 cells, but an opposite effect was detected in Caco-2 cells following transfection with miR-146a mimic. Therefore, our results are indicating that overexpression of miR-146a, despite downregulation of oncogenic CXCR4, may not lead to a universal tumor suppressive effect in all CRC cells, and this is possibly due to differences in miR-146a effects on signaling pathways in each cell type. Selection of miR-146a for tumor suppression requires enough details regarding the signaling profile of cancer cells otherwise it may produce unexpected outcome.

摘要

趋化因子受体 4(CXCR4)在结直肠癌(CRC)的发展和转移中发挥重要作用。一些先前的研究表明,CXCR4 是癌症的治疗靶点。CXCR4 是 miR-146a 的直接靶标。本研究旨在探讨外源性诱导 miR-146a 如何影响 CRC 细胞的 CXCR4 基因和蛋白表达以及增殖、凋亡和迁移。用合成的 miR-146a 模拟物转染 Caco-2 和 SW480 细胞,导致 CXCR4 基因和蛋白水平的表达下调。它还下调了几个 miR-146a 靶基因的表达,包括 GSK3B、IRAK1、TRAF6、AKT2、SMAD4、EGFR 和 NFKB1,主要在 SW480 细胞中。miR-146a 的过表达导致两个细胞系的细胞周期部分停滞,而凋亡率也降低。关于上皮-间充质转化因子,VIM 在两个细胞系中下调,但 SNAI1 在 Caco-2 细胞中上调。划痕闭合实验显示,SW480 细胞的细胞迁移减少,但转染 miR-146a 模拟物后 Caco-2 细胞的迁移则相反。因此,我们的结果表明,尽管 CXCR4 的致癌作用下调,但过表达 miR-146a 可能不会导致所有 CRC 细胞产生普遍的肿瘤抑制作用,这可能是由于 miR-146a 对每种细胞类型的信号通路的影响存在差异。选择 miR-146a 进行肿瘤抑制需要足够的关于癌细胞信号谱的细节,否则可能会产生意想不到的结果。

相似文献

1
MiR-146a suppresses the expression of CXCR4 and alters survival, proliferation and migration rate in colorectal cancer cells.miR-146a 抑制 CXCR4 的表达并改变结直肠癌细胞的存活、增殖和迁移率。
Tissue Cell. 2021 Dec;73:101654. doi: 10.1016/j.tice.2021.101654. Epub 2021 Sep 20.
2
Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.miR-9的下调通过调控结直肠癌细胞中的anoctamin-1(ANO1)促进上皮间质转化。
Cancer Genet. 2019 Feb;231-232:22-31. doi: 10.1016/j.cancergen.2018.12.004. Epub 2018 Dec 27.
3
MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.MiR-3622a-3p通过靶向spalt样转录因子4减少干性特征和上皮-间质转化,从而在结直肠癌中发挥肿瘤抑制作用。
Cell Death Dis. 2020 Jul 27;11(7):592. doi: 10.1038/s41419-020-02789-z.
4
TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.TRAIL 诱导的 miR-146a 表达抑制 CXCR4 介导的人乳腺癌迁移。
FEBS J. 2013 Jul;280(14):3340-53. doi: 10.1111/febs.12323. Epub 2013 Jun 3.
5
microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.微小RNA-335通过靶向Twist1抑制结直肠癌HCT116细胞的生长和上皮-间质转化(EMT)过程。
Pharmazie. 2017 Aug 1;72(8):475-481. doi: 10.1691/ph.2017.7489.
6
miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.miR-330 通过下调 HMGA2 抑制 EMT 并诱导人结直肠癌细胞凋亡。
J Cell Physiol. 2020 Feb;235(2):920-931. doi: 10.1002/jcp.29007. Epub 2019 Jun 26.
7
Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-catenin pathway and EMT in colorectal cancer.hsa-miR-425-5p 通过激活 CTNND1 介导的 β-连环蛋白通路和 EMT 促进结直肠癌的肿瘤生长和转移。
Cell Cycle. 2020 Aug;19(15):1917-1927. doi: 10.1080/15384101.2020.1783058. Epub 2020 Jun 28.
8
Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancer.miR-146a 的下调促进了幽门螺杆菌阴性胃癌细胞的迁移。
J Cell Biochem. 2019 Jun;120(6):9495-9505. doi: 10.1002/jcb.28225. Epub 2018 Dec 9.
9
miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.miR-133b 是一种肌肉特异性 microRNA,作为一种新型预后标志物,通过调节 CXCR4 表达参与了人结直肠癌的进展。
Mol Cancer. 2013 Dec 13;12:164. doi: 10.1186/1476-4598-12-164.
10
MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.微小RNA-206通过下调NOTCH3抑制结直肠癌的肿瘤增殖和迁移。
Oncol Rep. 2015 Mar;33(3):1402-10. doi: 10.3892/or.2015.3731. Epub 2015 Jan 19.

引用本文的文献

1
IL-6-induced long noncoding RNA MIR3142HG promotes tumorigenesis by interacting with thioredoxin-1 and STAT3 in human colorectal cancer.白细胞介素-6诱导的长链非编码RNA MIR3142HG通过与人结直肠癌中的硫氧还蛋白-1和信号转导子与转录激活子3相互作用促进肿瘤发生。
Cell Mol Biol Lett. 2025 May 22;30(1):61. doi: 10.1186/s11658-025-00742-6.
2
Targeting the chemokine receptor CXCR4 for cancer therapies.以趋化因子受体CXCR4为靶点进行癌症治疗。
Biomark Res. 2025 May 1;13(1):68. doi: 10.1186/s40364-025-00778-y.
3
MicroRNA-122 overexpression suppresses the colon cancer cell proliferation by downregulating the astrocyte elevated gene-1/metadherin oncoprotein.
微小RNA-122的过表达通过下调星形胶质细胞升高基因-1/黏附素原癌蛋白来抑制结肠癌细胞增殖。
Ann Med. 2025 Dec;57(1):2478311. doi: 10.1080/07853890.2025.2478311. Epub 2025 Apr 10.
4
A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.关于微小RNA作为喉癌预后生物标志物的批判性综述
Int J Mol Sci. 2024 Dec 16;25(24):13468. doi: 10.3390/ijms252413468.
5
Inhibition of Lymphangiogenesis: A Protective Role of microRNA 146a-5p in Breast Cancer.淋巴管生成的抑制:微小RNA 146a-5p在乳腺癌中的保护作用
Breast J. 2024 Aug 21;2024:7813083. doi: 10.1155/2024/7813083. eCollection 2024.
6
Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform.长期严重缺氧适应诱导非经典 EMT 和新型 Wilms 瘤 1(WT1)异构体。
Cancer Gene Ther. 2024 Aug;31(8):1237-1250. doi: 10.1038/s41417-024-00795-3. Epub 2024 Jul 8.
7
Expression profiles of host miRNAs and circRNAs and ceRNA network during Toxoplasma gondii lytic cycle.弓形虫裂解周期中宿主 miRNAs 和 circRNAs 的表达谱及 ceRNA 网络。
Parasitol Res. 2024 Feb 29;123(2):145. doi: 10.1007/s00436-024-08152-x.
8
Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential.肿瘤坏死因子受体相关因子6与人类癌症:关于机制见解、功能作用及治疗潜力的系统综述
J Cancer. 2024 Jan 1;15(2):560-576. doi: 10.7150/jca.90059. eCollection 2024.
9
Enterovirus 71 induces pyroptosis of human neuroblastoma SH-SY5Y cells through miR-146a/ CXCR4 axis.肠道病毒71型通过miR-146a/CXCR4轴诱导人神经母细胞瘤SH-SY5Y细胞焦亡。
Heliyon. 2023 Mar 29;9(4):e15014. doi: 10.1016/j.heliyon.2023.e15014. eCollection 2023 Apr.
10
MicroRNA-146a Promotes Embryonic Stem Cell Differentiation towards Vascular Smooth Muscle Cells through Regulation of Kruppel-like Factor 4.微小 RNA-146a 通过调节 Kruppel 样因子 4 促进胚胎干细胞向血管平滑肌细胞分化。
Curr Med Sci. 2023 Apr;43(2):223-231. doi: 10.1007/s11596-023-2736-3. Epub 2023 Apr 19.